Medication can significantly improve the ability to initiate tasks, sustain attention, and complete responsibilities”— ...

Jakob Roze, CSCS, is a health writer and high-end personal trainer. He is the founder and CEO of RozeFit, a high-end concierge personal training practice and online blog. The downward dogs and cat-cow ...

Altimmune (ALT) is advancing pemvidutide, a dual GLP-1/glucagon agonist, into a pivotal Phase 3 MASH trial in 2026.